Viewing Study NCT03092856


Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2026-05-30 @ 8:07 AM
Study NCT ID: NCT03092856
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2017-03-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer
Sponsor: University of Southern California
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clear Cell Renal Cell Carcinoma View
None Metastatic Renal Cell Cancer View
None Recurrent Renal Cell Carcinoma View
None Stage IV Renal Cell Cancer View
Keywords: